Bitte benutzen Sie diese Kennung, um auf die Ressource zu verweisen: https://doi.org/10.21256/zhaw-21157
Publikationstyp: Beitrag in wissenschaftlicher Zeitschrift
Art der Begutachtung: Peer review (Publikation)
Titel: Suicidality and other severe psychiatric events with duloxetine : re-analysis of safety data from a placebo-controlled trial for juvenile fibromyalgia
Autor/-in: Hengartner, Michael Pascal
Plöderl, Martin
et. al: No
DOI: 10.3233/JRS-200033
10.21256/zhaw-21157
Erschienen in: International Journal of Risk & Safety in Medicine
Erscheinungsdatum: 2020
Verlag / Hrsg. Institution: IOS Press
ISSN: 0924-6479
1878-6847
Sprache: Englisch
Schlagwörter: Duloxetine; Antidepressant; RCT; Suicidality; Suicidal ideation; Suicidal behavior; Serious adverse event
Fachgebiet (DDC): 615: Pharmakologie und Therapeutik
Zusammenfassung: BACKGROUND: In antidepressant trials for pediatric patients with depression or anxiety disorders, the risk of suicidal events and other severe psychiatric adverse events such as aggression and agitation is increased with antidepressants relative to placebo. OBJECTIVE: To examine whether largely mentally healthy adolescents treated for a non-psychiatric condition are also at increased risk of suicidality and other severe psychiatric disorders. METHODS: This is a re-analysis of a placebo-controlled duloxetine trial for juvenile fibromyalgia based on the main journal article and additional data published in the online supplementary material and on ClinicalTrials.gov. Both serious adverse events related to psychiatric disorders and adverse events leading to treatment discontinuation were defined as severe treatment-emergent psychiatric adverse events. RESULTS: We found that a significant portion of adolescents had treatment-emergent suicidal ideation and behaviour as well as other severe psychiatric adverse events with duloxetine, but no such events were recorded on placebo. The incidence of severe treatment emergent psychiatric adverse events was statistically significantly higher with duloxetine as compared to placebo. CONCLUSIONS: Antidepressants may put adolescents at risk of suicidality and other severe psychiatric disorders even when the treatment indication is not depression or anxiety.
Weitere Angaben: The final publication is available at IOS Press through http://dx.doi.org/10.3233/JRS-200033
URI: https://digitalcollection.zhaw.ch/handle/11475/21157
Volltext Version: Akzeptierte Version
Lizenz (gemäss Verlagsvertrag): Lizenz gemäss Verlagsvertrag
Departement: Angewandte Psychologie
Organisationseinheit: Psychologisches Institut (PI)
Enthalten in den Sammlungen:Publikationen Angewandte Psychologie

Dateien zu dieser Ressource:
Datei Beschreibung GrößeFormat 
2020_Hengartner-Ploederl_Duloxetine-Severe-Psychiatric-AE.pdfAccepted Version263.29 kBAdobe PDFMiniaturbild
Öffnen/Anzeigen


Alle Ressourcen in diesem Repository sind urheberrechtlich geschützt, soweit nicht anderweitig angezeigt.